New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 15, 2014
09:16 EDTKO, PESI, HALO, MS, INFY, BHP, POT, ZBRA, MSI, JNJ, AANOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Coca-Cola (KO), up 2.2%... Johnson & Johnson (JNJ), up 2.1%. ALSO HIGHER: Zebra Technologies (ZBRA), up 5.5% after agreeing to acquire Motorola Solution's (MSI) enterprise unit for $3.45B. Motorola Solutions shares are up 3.5% following the news... Halozyme (HALO), up 8.5% after initiated with Buy rating at Citigroup... Potash (POT), up 2.3% after Globe & Mail says the company is speculated to be targeted again by BHP Billiton (BHP)... Morgan Stanley (MS), up 2% after upgraded at BofA Merrill Lynch. DOWN AFTER EARNINGS: Infosys (INFY), down 2.5%... Perma-fix (PESI), down 8.9%. ALSO LOWER: Aaron's (AAN), down 5% after cuttings Q1 EPS and revenue guidance, acquiring Progressive Finance Holdings for $700M, and rejecting Vintage Capital's takeover offer.
News For KO;JNJ;MSI;ZBRA;POT;BHP;INFY;MS;HALO;PESI;AAN From The Last 14 Days
Check below for free stories on KO;JNJ;MSI;ZBRA;POT;BHP;INFY;MS;HALO;PESI;AAN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
August 27, 2014
12:39 EDTMSDow Chemical looking to sell Angus Chemical, AgroFresh units, Reuters reports
Subscribe for More Information
10:13 EDTINFYHigh option volume stocks
Subscribe for More Information
08:00 EDTMSSEC seen completing rules on MBS detail disclosures, WSJ says
The Securities and Exchange Commission is expected to complete rules requiring banks and other financial institutions to give investors greater detail about the quality of mortgages and other loans pooled into bonds known as asset-backed securities, reported The Wall Street Journal. Publicly traded big U.S banks include Bank of America (BAC), Citigroup (C), Goldman Sachs (GS), JPMorgan (JPM), Morgan Stanley (MS), U.S. Bancorp (USB) and Wells Fargo (WFC). Reference Link
07:34 EDTPESIPerma-fix granted Notice of Allowance from U.S. Patent Office
Perma-Fix subsidiary Perma-Fix Medical S.A. announced that in mid-August, the US Patent Office issued a notice of allowance to Perma-Fix Environmental Services allowing all claims in its recent patent application for preparation of its Microporous Composite Material and its derivatives. Perma-Fix Medical has a Patent License Agreement with Perma-Fix Environmental Services, for the production of Tc-99m, the proprietary resin that Perma-Fix manufactures.
06:58 EDTMSMorgan Stanley wins $15M arbitration suit vs. Schwab, Reuters says
A Financial Regulatory Authority arbitration panel in San Francisco ruled that Morgan Stanley (MS) won a $15M arbitration lawsuit against Charles Schwab (SCHW), who accused the bank of unlawfully recruiting brokers from a Schwab San Francisco division that left with confidential data, according to Reuters, citing comments from a Charles Schwab spokesman. The ruling ended a disagreement which had lasted two years. Reference Link
August 26, 2014
08:30 EDTMSConcerns about payment disintermediation overdone, says Pacific Crest
Subscribe for More Information
06:20 EDTKOCoca-Cola to introduce mid-calorie soda in Mexico, WSJ reports
Subscribe for More Information
August 25, 2014
15:16 EDTMSIFBI cancels plans for Motorola Solutions award after Relm protest, ModBee says
Subscribe for More Information
08:27 EDTJNJJanssen Affiliate Cilag acquires Covagen, terms not disclosed
Subscribe for More Information
07:03 EDTJNJVIVUS acquires patents from Janssen Pharmaceuticals
VIVUS (VVUS) announced the acquisition of a group of patents from Janssen Pharmaceuticals (JNJ) covering uses of topiramate as monotherapy and in combination with other pharmaceutical agents to treat a variety of medical conditions. Janssen has agreed to dismiss the lawsuit it brought against VIVUS on August 22, 2014 in the U.S. District Court for the District of Delaware. VIVUS will pay a one-time upfront fee and a royalty to Janssen on Qsymia product sales for an assignment of these topiramate-related patents owned by Janssen. VIVUS has an option to buy out the royalty for a predetermined amount.
August 21, 2014
13:06 EDTPESI R. Scott Asen reports 6.59% passive stake in Perma-fix Environmental
Subscribe for More Information
12:50 EDTMSDeutsche Bank divests natgas trading book to Morgan Stanley, Reuters says
Subscribe for More Information
08:31 EDTMSMorgan Stanley, JP Morgan selected by Shake Shack to lead IPO, Reuters says
JP Morgan (JPM) and Morgan Stanley (MS) have been picked by Shake Shack to lead the fast-food restaurant chain's IPO, sources tell Reuters. The offering could come as early as this year. Reference Link
08:31 EDTAANAaron's appoints Gilbert Danielson interim CEO
Subscribe for More Information
06:43 EDTMSRegulators up bank warning efforts for poor risk assessment, Reuters says
Subscribe for More Information
05:42 EDTJNJIllumina announces strategic partnership with AstraZeneca, Sanofi, Janssen
Illumina (ILMN) announced it has formed collaborative partnerships with leading pharmaceutical companies to develop a universal next-generation sequencing, or NGS,-based oncology test system. The system will be used for clinical trials of targeted cancer therapies with a goal of developing and commercializing a multi-gene panel for therapeutic selection, resulting in a more comprehensive tool for precision medicine. Initial strategic partners include AstraZeneca (AZN), Janssen Biotech, a Johnson & Johnson (JNJ) company, and Sanofi (SNY). Illumina is working with the strategic partners to develop assays that detect and measure multiple variants simultaneously to support partners’ clinical trials, with the objectives of securing regulatory agency approvals and test commercialization. In parallel, Illumina is working with key thought leaders to set standards for NGS-based assays in routine clinical oncology practice, as well as to define regulatory frameworks to enable this new testing paradigm. Together, Illumina and its strategic partners aim to transition from single-analyte companion diagnostics to panel-based assays that select for “companion therapeutics.”
August 20, 2014
18:29 EDTMSBofA, JPMorgan weigh plans to raise salaries for junior bankers, Bloomberg says
Subscribe for More Information
10:04 EDTBHPOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: BHP Billiton (BHP) downgraded to Underperform from Neutral at Credit Suisse... GT Advanced (GTAT) downgraded to Underperform from Outperform at CLSA... Hertz (HTZ) downgraded to Hold from Buy at Deutsche Bank... IDEXX (IDXX) downgraded to Sell from Neutral at Northcoast... Prestige Brands (PBH) downgraded to Neutral from Buy at Sidoti... Real Goods Solar (RGSE) downgraded to Neutral from Buy at Roth Capital... Regal-Beloit (RBC) downgraded to Neutral from Buy at Longbow... SunCoke Energy (SXC) downgraded to Neutral from Outperform at Credit Suisse... Tidewater (TDW) downgraded to Market Perform from Outperform at Clarkson Capital.
09:09 EDTINFYFairchild Semiconductor volatility expected to move on deal report
Subscribe for More Information
05:20 EDTBHPBHP Billiton downgraded to Underperform from Neutral at Credit Suisse
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use